SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025998
Filing Date
2022-12-02
Accepted
2022-12-02 16:13:06
Documents
14
Period of Report
2022-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20221130.htm   iXBRL 8-K 60458
2 EX-4.1 agen-ex4_1.htm EX-4.1 171628
3 EX-4.2 agen-ex4_2.htm EX-4.2 171628
  Complete submission text file 0000950170-22-025998.txt   561624

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agen-20221130_lab.xml EX-101.LAB 12986
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agen-20221130_pre.xml EX-101.PRE 10501
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agen-20221130.xsd EX-101.SCH 2467
8 EXTRACTED XBRL INSTANCE DOCUMENT agen-20221130_htm.xml XML 4495
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 221442074
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences